the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Company profile
Ticker
VERU
Exchange
Website
CEO
Mitchell Steiner
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
FEMALE HEALTH CO
SEC CIK
Corporate docs
Subsidiaries
Aspen Park Pharmaceuticals, Inc. • Badger Acquisition Sub, Inc. • The Female Health Company Limited • The Female Health Company (UK) Plc. • The Female Health Company • Veru International Holdco Inc. • Veru Biopharma UK Limited • Veru Biopharma Europe Limited • Veru Biopharma Netherlands B.V. ...
IRS number
391144397
VERU stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
1 Apr 24
10-Q
2024 Q1
Quarterly report
1 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Feb 24
NT 10-Q
Notice of late quarterly filing
15 Feb 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
15 Feb 24
8-K
Veru Reports Fiscal 2024 First Quarter Financial Highlights
8 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Jan 24
DEFA14A
Additional proxy soliciting materials
26 Jan 24
Transcripts
VERU
Earnings call transcript
2024 Q1
8 Feb 24
VERU
Earnings call transcript
2023 Q2
9 Aug 23
VERU
Earnings call transcript
2023 Q1
11 May 23
VERU
Earnings call transcript
2023 Q1
9 Feb 23
VERU
Earnings call transcript
2022 Q4
5 Dec 22
VERU
Earnings call transcript
2022 Q3
11 Aug 22
VERU
Earnings call transcript
2022 Q2
12 May 22
VERU
Earnings call transcript
2022 Q1
9 Feb 22
VERU
Earnings call transcript
2021 Q4
2 Dec 21
VERU
Earnings call transcript
2021 Q3
12 Aug 21
Latest ownership filings
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G/A
FROST PHILLIP MD ET AL
6 Feb 24
SC 13G
ADAGE CAPITAL PARTNERS GP, L.L.C.
26 Dec 23
SC 13G/A
MORGAN STANLEY
8 Dec 23
4
Michael L Rankowitz
17 Nov 23
4
Mario Eisenberger
17 Nov 23
4
Lucy Lu
17 Nov 23
4
Grace Hyun
17 Nov 23
SC 13G/A
FROST PHILLIP MD ET AL
28 Sep 23
SC 13G/A
BlackRock Inc.
8 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
12.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 65 |
Opened positions | 3 |
Closed positions | 23 |
Increased positions | 14 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 9.32 bn |
Total shares | 18.06 mm |
Total puts | 506.00 k |
Total calls | 893.60 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Phillip MD Frost Et Al | 5.10 mm | $4.22 mm |
MS Morgan Stanley | 3.81 mm | $2.74 bn |
Vanguard | 3.54 mm | $2.54 bn |
BLK Blackrock | 1.18 mm | $845.27 mm |
Perceptive Advisors | 1.09 mm | $783.62 mm |
Millennium Management | 835.58 k | $600.79 mm |
Geode Capital Management | 600.11 k | $431.60 mm |
Blair William & Co | 330.00 k | $237.27 mm |
STT State Street | 217.06 k | $156.07 mm |
BAC Bank Of America | 154.57 k | $111.14 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Oct 23 | Grace Hyun | Common Stock Option Common Stock | Grant | Acquire A | No | No | 0.73 | 60,000 | 43.80 k | 60,000 |
2 Oct 23 | Lucy Lu | Common Stock Option Common Stock | Grant | Acquire A | No | No | 0.73 | 80,000 | 58.40 k | 80,000 |
2 Oct 23 | Mario Eisenberger | Common Stock Option Common Stock | Grant | Acquire A | No | No | 0.73 | 70,000 | 51.10 k | 70,000 |
2 Oct 23 | Michael L Rankowitz | Common Stock Option Common Stock | Grant | Acquire A | No | No | 0.73 | 90,000 | 65.70 k | 90,000 |
9 May 23 | Mario Eisenberger | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.37 | 15,000 | 20.55 k | 15,000 |
News
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
15 Apr 24
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
15 Apr 24
Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5
15 Apr 24
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
12 Apr 24
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
9 Apr 24
Press releases
Veru Announces Date of 2024 Annual Meeting of Shareholders
1 Apr 24
Veru Reschedules Annual Meeting of Shareholders
22 Mar 24
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
27 Feb 24
Biotech With Potential: Coeptis Therapeutics (COEP) And 3 Underrated Gems
21 Feb 24
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN
20 Feb 24